Search research articles
Contact Us
Filters
Showing results (121-130 of 131) with videos related to
Page
of 14
Sort By:
Science Advances
|
March 2, 2022
Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors
Amanda M Nash, Maria I Jarvis, Samira Aghlara-Fotovat, et al.
Cancer Research Communications
|
August 29, 2024
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer
Matthew T Campbell, Amishi Y Shah, Pavlos Msaouel, et al.
Nature Communications
|
November 5, 2021
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma
Matthew T Campbell, Surena F Matin, Alda L Tam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation
Sandra L Grimm, Menuka Karki, Kyle A Blum, et al.
The Oncologist
|
August 7, 2015
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma
Lipika Goyal, Aparna Govindan, Rahul A Sheth, et al.
Nature Communications
|
January 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial
Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2025
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors
Blessie Elizabeth Nelson, Filip Janku, Siqing Fu, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2024
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Jason J Luke, Diwakar Davar, Robert H Andtbacka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma
Kai Yu, Rebecca S Tidwell, Tharakeswara K Bathala, et al.
Cell Reports. Medicine
|
October 31, 2025
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling
Pavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 131) with videos related to
Sort By:
Page
of 14
Science Advances
|
March 2, 2022
Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors
Amanda M Nash, Maria I Jarvis, Samira Aghlara-Fotovat, et al.
Cancer Research Communications
|
August 29, 2024
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer
Matthew T Campbell, Amishi Y Shah, Pavlos Msaouel, et al.
Nature Communications
|
November 5, 2021
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma
Matthew T Campbell, Surena F Matin, Alda L Tam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation
Sandra L Grimm, Menuka Karki, Kyle A Blum, et al.
The Oncologist
|
August 7, 2015
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma
Lipika Goyal, Aparna Govindan, Rahul A Sheth, et al.
Nature Communications
|
January 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial
Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2025
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors
Blessie Elizabeth Nelson, Filip Janku, Siqing Fu, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2024
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Jason J Luke, Diwakar Davar, Robert H Andtbacka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma
Kai Yu, Rebecca S Tidwell, Tharakeswara K Bathala, et al.
Cell Reports. Medicine
|
October 31, 2025
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling
Pavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Page
of 14